DeepSeek Slashes Flagship AI Model Price by 75 in Permanent Reduction HALO Stocks Emerge as New Investment Theme Buying What AI Cant Replace Hong Kong Surpasses Switzerland as Leading Offshore Wealth Hub in 2025 Telecom Stocks Surge on SpaceX IPO Hype but Historical Patterns Suggest Caution China Calls for APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business Andy Burnhams Manchester Spirit Could a Mix of Collectivism and Entrepreneurialism Reshape UK Policy SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market My Size Inc MYSZ Q4 2025 Earnings EPS Falls Short of Expectations Amid Revenue Disclosures Cencora COR Q1 2026 Earnings EPS Misses Estimates But Stock Rises on Resilient Operations PETS Q1 2026 Earnings Significant Earnings Miss Despite Positive Stock Reaction Nexgen Energy Ltd NXE Q1 2026 Earnings Deep EPS Miss as PreRevenue Developer Advances Key Projects ERII Q1 2026 Earnings EPS Misses Expectations Despite Positive Stock Reaction Lifezone Metals LZM Surges Over 8 Testing Key Resistance at 534 Beam Therapeutics BEAM Edges Higher as Investors Weigh Gene Editing Sector Outlook Greenwich LifeSciences GLSI Surges 7 as Biotech Momentum Builds Molson Coors TAP Holds Steady Near Key Support as Trading Volume Remains Muted First United Corporation FUNC Gains 155 as Stock Approaches Key Resistance Level Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins RYTM Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Atomera ATOM Surges Over 31 as Momentum Builds Above Key Support HIW Q1 2026 Earnings Massive EPS Surprise of 161 Drives Stock Rally TrueBlue Q1 2026 Earnings EPS Surprises with 979 Beat Amid Labor Market Uncertainty ARDX Q1 2026 Earnings EPS Misses Estimates by 142 Revenue Not Disclosed Auddia Inc AUUD Q1 2025 Earnings EPS Misses Estimates by a Wide Margin Amid No Revenue BOTJ Q1 2025 Earnings EPS of 019 Reported Stock Edges Higher FFWM Q4 2025 Earnings Significant EPS Miss Amidst Challenging Environment DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus